Teizo Yoshimura

Okayama, 7008558, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 78 publications

Advances in Immune Checkpoint Inhibitors for Cancer Treatment.

Advances in Immune Checkpoint Inhibitors for Cancer Treatment.

Journal: Cancers

Published: April 21, 2026

CXCR2-Dependent Infiltration of Tumor-Associated Neutrophils Is Linked to Enhanced CD8+ T Cell Effector Function and Reduced Lung Metastasis in 4T1 Breast Cancer.

CXCR2-Dependent Infiltration of Tumor-Associated Neutrophils Is Linked to Enhanced CD8+ T Cell Effector Function and Reduced Lung Metastasis in 4T1 Breast Cancer.

Journal: International journal of molecular sciences

Published: March 01, 2026

SPRED2 suppresses the stemness of hepatocellular carcinoma through the p53/miR-506-3p/KLF4 pathway.

SPRED2 suppresses the stemness of hepatocellular carcinoma through the p53/miR-506-3p/KLF4 pathway.

Journal: Cancer biology & medicine

Published: January 21, 2026

Neurofibromin Encoded by the Neurofibromatosis Type 1 (NF1) Gene Promotes the Membrane Translocation of SPRED2, Thereby Inhibiting the ERK Pathway in Breast Cancer Cells.

Neurofibromin Encoded by the Neurofibromatosis Type 1 (NF1) Gene Promotes the Membrane Translocation of SPRED2, Thereby Inhibiting the ERK Pathway in Breast Cancer Cells.

Journal: International journal of molecular sciences

Published: September 23, 2025

Pseudohypoxia induced by iron chelator activates tumor immune response in lung cancer.

Pseudohypoxia induced by iron chelator activates tumor immune response in lung cancer.

Journal: Free radical research

Published: August 24, 2025

SPRED2 controls the severity of cisplatin-induced acute kidney injury by inhibiting ERK activation and TNFα production in mice.

SPRED2 controls the severity of cisplatin-induced acute kidney injury by inhibiting ERK activation and TNFα production in mice.

Journal: Biochimica et biophysica acta. Molecular cell research

Published: July 22, 2025

HIF-PH inhibitors induce pseudohypoxia in T cells and suppress the growth of microsatellite stable colorectal cancer by enhancing antitumor immune responses.

HIF-PH inhibitors induce pseudohypoxia in T cells and suppress the growth of microsatellite stable colorectal cancer by enhancing antitumor immune responses.

Journal: Cancer immunology, immunotherapy : CII

Published: September 28, 2024

SPRED2 Is a Novel Regulator of Autophagy in Hepatocellular Carcinoma Cells and Normal Hepatocytes.

SPRED2 Is a Novel Regulator of Autophagy in Hepatocellular Carcinoma Cells and Normal Hepatocytes.

Journal: International journal of molecular sciences

Published: May 02, 2024

Exosomal delivery of miR-200b-3p suppresses the growth of hepatocellular carcinoma cells by targeting ERG- and VEGF-mediated angiogenesis.

Exosomal delivery of miR-200b-3p suppresses the growth of hepatocellular carcinoma cells by targeting ERG- and VEGF-mediated angiogenesis.

Journal: Gene

Published: April 12, 2024

The specific shapes of capillaries are associated with worse prognosis in patients with invasive breast cancer.

The specific shapes of capillaries are associated with worse prognosis in patients with invasive breast cancer.

Journal: Pathology international

Published: April 11, 2024

Expression of SPRED2 in the lung adenocarcinoma.

Expression of SPRED2 in the lung adenocarcinoma.

Journal: Pathology, research and practice

Published: April 10, 2024

Correction: The beneficial effects of commensal E. coli for colon epithelial cell recovery are related with Formyl peptide receptor 2 (Fpr2) in epithelial cells.

Correction: The beneficial effects of commensal E. coli for colon epithelial cell recovery are related with Formyl peptide receptor 2 (Fpr2) in epithelial cells.

Journal: Gut pathogens

Published: December 01, 2023

Showing 1-12 of 78

Last Updated: 09/26/2026